A Phase 1 clinical study of vaporized PPP001 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2018
At a glance
- Drugs Marijuana (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Pharmacokinetics
- 01 Nov 2018 According to a Tetra Bio Pharma media release, the company has obtained approval from Health Canada to conduct this trial and expects to begin and end the trial in Q4 2018.
- 27 Sep 2018 New trial record
- 20 Sep 2018 According to a Tetra Bio Pharma media release, the company is planning to initiate this trial later this year.